Go Pro
→ They proved it worked in '76. Then buried it. (From Behind the Markets) (Ad)tc pixel Free LOGC Stock Alerts

LogicBio Therapeutics (LOGC) Short Interest Ratio & Short Volume

LogicBio Therapeutics logo
$8.91 +0.01 (+0.11%)
As of 07/1/2026 03:58 PM Eastern
Compare

LogicBio Therapeutics Short Interest Overview

As of June 15, 2026, LogicBio Therapeutics (LOGC) had a short interest of 533,584 shares sold short, representing 2.03% of the public float. This marks a -1.03% decrease in short interest since the prior report. The short interest ratio (days to cover) is 2.4, meaning it would take 2.4 days of the average trading volume of 159,752 shares to cover all short positions.

Current Short Interest
533,584 shares
Previous Short Interest
539,144 shares
Change Vs. Previous Month
-1.03%
Dollar Volume Sold Short
$5.18 million
Short Interest Ratio
2.4 Days to Cover
Last Record Date
June 15, 2026
Outstanding Shares
45,730,000 shares
Short Percent of Float
2.03%
Today's Trading Volume
63,804 shares
Average Trading Volume
159,752 shares
Today's Volume Vs. Average
40%
Short Selling LogicBio Therapeutics?
A Guide To High-Short-Interest Stocks

Sign up to receive the latest short interest report for LogicBio Therapeutics and its competitors with MarketBeat's FREE newsletter.

Get Report
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Charts & View Short Interest History
Short Interest ChartDays to Cover ChartShort Percent of Float Chart

LOGC Short Interest Over Time

LOGC Days to Cover Over Time

LOGC Percentage of Float Shorted Over Time

LogicBio Therapeutics Tesla Short Interest History & Recent Changes

Export
Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
6/15/2026533,584 shares $5.18 million -1.0%2.0%2.43 $9.71
5/29/2026539,144 shares $4.84 million -3.2%2.0%1.58 $8.98
5/15/2026556,723 shares $4.80 million -0.2%2.1%5.32 $8.63
4/30/2026557,865 shares $4.75 million -0.3%2.1%3.63 $8.52
4/15/2026559,586 shares $4.90 million -1.3%2.1%4.76 $8.75
3/31/2026567,194 shares $4.57 million -0.2%2.2%3.51 $8.06
2/27/2026515,641 shares $4.11 million -40.2%2.0%1.08 $7.98
10/15/2025610,000 shares $4.73 million -9.9%2.5%4.4 $7.75
9/30/2025677,100 shares $5.41 million -15.2%N/A2.4 $7.99
9/15/2025798,100 shares $6.25 million -8.1%N/A5 $7.83
8/31/2025868,100 shares $6.44 million -7.1%3.6%11.9 $7.42
8/15/2025934,400 shares $6.89 million -10.5%N/A7.2 $7.37
7/31/20251,044,400 shares $7.96 million -6.0%4.3%5.6 $7.62
7/15/20251,110,600 shares $7.94 million -6.0%N/A4.7 $7.15
6/30/20251,181,400 shares $7.86 million -24.0%4.9%1.6 $6.65
6/15/20251,555,300 shares $12.71 million -31.0%6.4%0.6 $8.17
5/31/20252,250,000 shares $18.45 million -2.2%9.5%4.4 $8.20
5/15/20252,300,000 shares $16.95 million -9.8%9.7%6.4 $7.37
4/30/20252,550,000 shares $18.21 million -2.3%10.9%7.5 $7.14
4/15/20252,610,000 shares $17.12 million No Change11.1%7.9 $6.56
3/31/20252,610,000 shares $18.14 million +2.0%11.1%8.7 $6.95
3/15/20252,560,000 shares $19.32 million +1.6%10.9%9 $7.55
2/28/20252,520,000 shares $21.70 million +1.6%10.7%9.1 $8.61
2/15/20252,480,000 shares $19.69 million -2.4%10.6%10 $7.94
1/31/20252,540,000 shares $18.85 million -6.3%10.8%10.9 $7.42
1/15/20252,710,000 shares $17.51 million -0.4%11.5%10.9 $6.46
12/31/20242,720,000 shares $19.26 million -3.2%11.6%10.3 $7.08
12/15/20242,810,000 shares $21.05 million -5.1%12.0%10.1 $7.49
11/30/20242,960,000 shares $21.16 million -7.2%13.2%10.6 $7.15
11/15/20243,190,000 shares $20.37 million -2.5%14.2%11.9 $6.39
10/31/20243,270,000 shares $21.22 million -0.9%14.2%12.5 $6.49
10/15/20243,300,000 shares $19.44 million +25.0%14.9%11.8 $5.89
9/30/20242,640,000 shares $14.39 million -15.7%12.0%9.5 $5.45
9/15/20243,130,000 shares $16.68 million +20.4%14.2%9.5 $5.33
8/31/20242,600,000 shares $14.04 million -6.1%11.9%7.5 $5.40
8/15/20242,770,000 shares $15.15 million +14.0%12.7%7.3 $5.47
7/31/20242,430,000 shares $13.12 million -33.8%12.0%5.8 $5.40
7/15/20243,670,000 shares $22.39 million No Change18.1%6.9 $6.10
10/31/2022274,400 shares $562.52 thousand +104.9%1.3%0.5 $2.05
10/15/2022133,900 shares $274.50 thousand +159.5%0.7%0.3 $2.05
Solar is dead. Here’s what replaces it. (Ad)

Starting July 4th, every new solar and wind project in America loses its federal tax credits. But one zero-carbon energy source retains full government backing for eight more years - and it runs around the clock without batteries. Investment in this sector has surged 100x in seven years. The Pentagon named it a top energy priority, California mandated it, and Google, Meta, and Berkshire Hathaway are already under contract. One company controls the entire chain from the ground to the grid.tc pixel

See the last clean energy source with full government backing
9/30/202251,600 shares $14.06 thousand +77.3%0.3%0.1 $0.27
9/15/202229,100 shares $10.91 thousand -61.1%0.2%0.2 $0.38
8/31/202274,800 shares $26.81 thousand -2.7%0.4%0.4 $0.36
8/15/202276,900 shares $39.60 thousand +18.7%0.4%0.3 $0.52
7/31/202264,800 shares $25.43 thousand -8.7%0.4%0.1 $0.39
7/15/202271,000 shares $27.69 thousand +110.7%0.4%0.1 $0.39
6/30/202233,700 shares $11.80 thousand -75.8%0.2%0 $0.35
6/15/2022139,100 shares $60.51 thousand -37.6%0.8%0.1 $0.44
5/31/2022222,800 shares $111.40 thousand -57.6%1.2%0.2 $0.50
5/15/2022526,000 shares $226.18 thousand +952.0%2.9%0.4 $0.43
4/30/202250,000 shares $22 thousand -60.9%0.3%0 $0.44
4/15/2022127,800 shares $86.14 thousand -0.1%0.7%0.4 $0.67
3/31/2022127,900 shares $86.98 thousand -10.0%0.7%0.4 $0.68
3/15/2022142,100 shares $99.19 thousand -11.9%0.8%0.4 $0.70
2/28/2022161,200 shares $106.39 thousand -39.3%0.9%0.5 $0.66
2/15/2022265,500 shares $196.47 thousand +60.0%1.5%0.9 $0.74
1/31/2022165,900 shares $248.85 thousand -5.8%0.9%0.6 $1.50
1/15/2022176,100 shares $343.40 thousand -4.3%1.4%1.9 $1.95
12/31/2021184,000 shares $425.04 thousand -31.6%1.4%1.9 $2.31
12/15/2021268,800 shares $658.56 thousand -55.0%2.1%2.8 $2.45
11/30/2021597,600 shares $1.79 million -0.5%4.8%7.5 $3.00
11/15/2021600,300 shares $2.11 million -0.7%4.8%7.4 $3.52
10/29/2021604,200 shares $2.21 million +0.8%4.9%7.6 $3.65
10/15/2021599,700 shares $2.40 million +1.9%4.9%7.1 $4.00
9/30/2021588,400 shares $2.69 million +1.9%4.8%6.7 $4.58
9/15/2021577,200 shares $2.61 million +2.2%4.7%4.3 $4.53
8/31/2021564,900 shares $2.68 million -17.3%4.6%3.5 $4.74
8/13/2021682,800 shares $3.08 million -1.9%5.6%3.9 $4.51
7/30/2021696,300 shares $2.90 million -4.0%5.7%3.8 $4.17
7/15/2021724,900 shares $2.79 million -1.2%4.0%3.6 $3.85

LOGC Short Interest - Frequently Asked Questions

Short interest is the volume of LogicBio Therapeutics shares that have been sold short but have not yet been closed out or covered. As of June 15th, investors have sold 533,584 shares of LOGC short. 2.03% of LogicBio Therapeutics' shares are currently sold short. Learn More on LogicBio Therapeutics' current short interest.

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. LOGC shares currently have a short interest ratio of 2.4. Learn More on LogicBio Therapeutics's short interest ratio.

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 2.03% of LogicBio Therapeutics' floating shares are currently sold short.

LogicBio Therapeutics saw a decrease in short interest in June. As of June 15th, there was short interest totaling 533,584 shares, a decrease of 1.0% from the previous total of 539,144 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

2.03% of LogicBio Therapeutics' shares are currently sold short. Here is how the short interest of companies in the sector of "retail/wholesale" compare to LogicBio Therapeutics: SSP Group (0.03%), Ingles Markets, Incorporated (6.71%), Travis Perkins PLC (0.02%), TripAdvisor, Inc. (30.06%), Ryerson Holding (3.48%), Winmark Corporation (10.01%), Sally Beauty Holdings, Inc. (20.51%), The Wendy's Company (32.72%), Yesway, Inc. (2.14%), Herbalife Ltd (8.07%),

As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($77.25 billion), Invesco QQQ ($51.70 billion), iShares Russell 2000 ETF ($25.75 billion), Sandisk Corporation ($23.00 billion), Western Digital Corporation ($17.29 billion), Nebius Group N.V. ($13.25 billion), SPDR S&P Biotech ETF ($10.78 billion), KLA Corporation ($10.45 billion), Salesforce Inc. ($9.71 billion), and VanEck Semiconductor ETF ($9.01 billion). View all of the most shorted stocks.

Short selling LOGC is an investing strategy that aims to generate trading profit from LogicBio Therapeutics as its price is falling. LOGC shares are trading up $0.01 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for LogicBio Therapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of LOGC, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including LOGC, twice per month. The most recent reporting period available is June, 15 2026.

Understanding short interest metrics can help you assess how traders are positioning around a stock like LOGC:

  • Shares Sold Short: The total number of shares that have been sold by short sellers but have not yet been covered or closed out. A high number may indicate bearish sentiment.
  • Short Float: The percentage of a company’s publicly available shares (or "float") that are sold short. A higher short float suggests a greater portion of the stock is being bet against.
  • Days to Cover (Short Interest Ratio): This estimates how many days it would take short sellers to cover their positions, based on average daily trading volume. Higher values can signal potential for a short squeeze if buying pressure increases.

These metrics are often used by traders to gauge sentiment, volatility risk, and the potential for price movements based on short covering activity.


Related Companies
Short Interest Tools

This page (OTCMKTS:LOGC) was last updated on 6/25/2026 by MarketBeat.com Staff.
From Our Partners
Urgent exposé on the "Mar-a-Lago Trade"
Dr. David Eifrig, former Goldman Sachs VP and Senior Partner at Stansberry Research, has released an urgent ex...
Stansberry Research | Sponsoredtc pixel
SPCX Warning - and Worst News for Stocks in 50 Years
Goldman Sachs and Morgan Stanley are now predicting what could be the worst news for the U.S. stock market in ...
TradeSmith | Sponsoredtc pixel
The $15 Gold Fund That Pays Up to $1,152/Month
Gold is hitting record highs, but most investors are leaving income on the table. A $15 fund is quietly paying...
Investors Alley | Sponsoredtc pixel
Your $29.97 book is free today
Why Some Traders Skip Stocks Entirely You don't need a big account to trade options. In fact, options ca...
Profits Run | Sponsoredtc pixel
PH: Do THESE 4 things to your bank account now …
In a few short months, the US government could gain unprecedented powers over personal bank accounts - includi...
Weiss Ratings | Sponsoredtc pixel
What Happens to Your Assets If You Die Without a Will?
Without a will, your state's intestacy laws decide how your assets are divided — a rigid formula that ignores ...
SmartAsset | Sponsoredtc pixel
Elon Is Quietly Doubling Down on This Bizarre Asset
Yahoo Finance reports this technology 'May Unlock $400 Trillion' - and Bloomberg calls it 'unavoidable.' Elon ...
Brownstone Research | Sponsoredtc pixel
I paid $5,000 to hear Elon say this
One investor paid $5,000 to be in a private room with Elon Musk in Los Angeles - and what he heard confirmed a...
InvestorPlace | Sponsoredtc pixel